208 related articles for article (PubMed ID: 28675565)
1. Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardation.
Oprescu SN; Chepa-Lotrea X; Takase R; Golas G; Markello TC; Adams DR; Toro C; Gropman AL; Hou YM; Malicdan MCV; Gahl WA; Tifft CJ; Antonellis A
Hum Mutat; 2017 Oct; 38(10):1412-1420. PubMed ID: 28675565
[TBL] [Abstract][Full Text] [Related]
2. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.
Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A
Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514
[TBL] [Abstract][Full Text] [Related]
3. Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.
Kuo ME; Theil AF; Kievit A; Malicdan MC; Introne WJ; Christian T; Verheijen FW; Smith DEC; Mendes MI; Hussaarts-Odijk L; van der Meijden E; van Slegtenhorst M; Wilke M; Vermeulen W; Raams A; Groden C; Shimada S; Meyer-Schuman R; Hou YM; Gahl WA; Antonellis A; Salomons GS; Mancini GMS
Am J Hum Genet; 2019 Mar; 104(3):520-529. PubMed ID: 30824121
[TBL] [Abstract][Full Text] [Related]
4. MARS variant associated with both recessive interstitial lung and liver disease and dominant Charcot-Marie-Tooth disease.
Rips J; Meyer-Schuman R; Breuer O; Tsabari R; Shaag A; Revel-Vilk S; Reif S; Elpeleg O; Antonellis A; Harel T
Eur J Med Genet; 2018 Oct; 61(10):616-620. PubMed ID: 29655802
[TBL] [Abstract][Full Text] [Related]
5. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.
Antonellis A; Lee-Lin SQ; Wasterlain A; Leo P; Quezado M; Goldfarb LG; Myung K; Burgess S; Fischbeck KH; Green ED
J Neurosci; 2006 Oct; 26(41):10397-406. PubMed ID: 17035524
[TBL] [Abstract][Full Text] [Related]
6. CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila.
Ermanoska B; Motley WW; Leitão-Gonçalves R; Asselbergh B; Lee LH; De Rijk P; Sleegers K; Ooms T; Godenschwege TA; Timmerman V; Fischbeck KH; Jordanova A
Neurobiol Dis; 2014 Aug; 68():180-9. PubMed ID: 24807208
[TBL] [Abstract][Full Text] [Related]
7. Novel GARS mutation presenting as autosomal dominant intermediate Charcot-Marie-Tooth disease.
Nan H; Takaki R; Hata T; Ichinose Y; Tsuchiya M; Koh K; Takiyama Y
J Peripher Nerv Syst; 2019 Mar; 24(1):156-160. PubMed ID: 30394614
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygous mutations in glycyl-tRNA synthetase are a proposed cause of systemic mitochondrial disease.
McMillan HJ; Schwartzentruber J; Smith A; Lee S; Chakraborty P; Bulman DE; Beaulieu CL; Majewski J; Boycott KM; Geraghty MT
BMC Med Genet; 2014 Mar; 15():36. PubMed ID: 24669931
[TBL] [Abstract][Full Text] [Related]
9. Compound heterozygosity for loss-of-function FARSB variants in a patient with classic features of recessive aminoacyl-tRNA synthetase-related disease.
Antonellis A; Oprescu SN; Griffin LB; Heider A; Amalfitano A; Innis JW
Hum Mutat; 2018 Jun; 39(6):834-840. PubMed ID: 29573043
[TBL] [Abstract][Full Text] [Related]
10. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.
Achilli F; Bros-Facer V; Williams HP; Banks GT; AlQatari M; Chia R; Tucci V; Groves M; Nickols CD; Seburn KL; Kendall R; Cader MZ; Talbot K; van Minnen J; Burgess RW; Brandner S; Martin JE; Koltzenburg M; Greensmith L; Nolan PM; Fisher EM
Dis Model Mech; 2009; 2(7-8):359-73. PubMed ID: 19470612
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Genetic Features in a Series of Eight Unrelated Patients with Neuropathy Due to Glycyl-tRNA Synthetase (GARS) Variants.
Forrester N; Rattihalli R; Horvath R; Maggi L; Manzur A; Fuller G; Gutowski N; Rankin J; Dick D; Buxton C; Greenslade M; Majumdar A
J Neuromuscul Dis; 2020; 7(2):137-143. PubMed ID: 31985473
[TBL] [Abstract][Full Text] [Related]
12. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.
Motley WW; Seburn KL; Nawaz MH; Miers KE; Cheng J; Antonellis A; Green ED; Talbot K; Yang XL; Fischbeck KH; Burgess RW
PLoS Genet; 2011 Dec; 7(12):e1002399. PubMed ID: 22144914
[TBL] [Abstract][Full Text] [Related]
13. Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction.
Nafisinia M; Riley LG; Gold WA; Bhattacharya K; Broderick CR; Thorburn DR; Simons C; Christodoulou J
PLoS One; 2017; 12(6):e0178125. PubMed ID: 28594869
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation of the glycyl-tRNA synthetase (GARS) gene associated with Charcot-Marie-Tooth type 2D in a Chinese family.
Sun A; Liu X; Zheng M; Sun Q; Huang Y; Fan D
Neurol Res; 2015 Sep; 37(9):782-7. PubMed ID: 26000875
[TBL] [Abstract][Full Text] [Related]
15. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
[TBL] [Abstract][Full Text] [Related]
16. Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease.
Malissovas N; Griffin LB; Antonellis A; Beis D
Hum Mol Genet; 2016 Apr; 25(8):1528-42. PubMed ID: 27008886
[TBL] [Abstract][Full Text] [Related]
17. The role of tRNA synthetases in neurological and neuromuscular disorders.
Boczonadi V; Jennings MJ; Horvath R
FEBS Lett; 2018 Mar; 592(5):703-717. PubMed ID: 29288497
[TBL] [Abstract][Full Text] [Related]
18. Four pedigrees with aminoacyl-tRNA synthetase abnormalities.
Okamoto N; Miya F; Tsunoda T; Kanemura Y; Saitoh S; Kato M; Yanagi K; Kaname T; Kosaki K
Neurol Sci; 2022 Apr; 43(4):2765-2774. PubMed ID: 34585293
[TBL] [Abstract][Full Text] [Related]
19. GARS-related disease in infantile spinal muscular atrophy: Implications for diagnosis and treatment.
Markovitz R; Ghosh R; Kuo ME; Hong W; Lim J; Bernes S; Manberg S; Crosby K; Tanpaiboon P; Bharucha-Goebel D; Bonnemann C; Mohila CA; Mizerik E; Woodbury S; Bi W; Lotze T; Antonellis A; Xiao R; Potocki L
Am J Med Genet A; 2020 May; 182(5):1167-1176. PubMed ID: 32181591
[TBL] [Abstract][Full Text] [Related]
20. Two novel mutations of GARS in Korean families with distal hereditary motor neuropathy type V.
Lee HJ; Park J; Nakhro K; Park JM; Hur YM; Choi BO; Chung KW
J Peripher Nerv Syst; 2012 Dec; 17(4):418-21. PubMed ID: 23279345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
